MTOR Pathway and MTOR Inhibitors in Cancer Therapy
. Ed(S): Polunovsky, V. A.; Houghton, Peter J.
€ 239.51
FREE Delivery in Ireland
Description for MTOR Pathway and MTOR Inhibitors in Cancer Therapy
Hardback. Editor(s): Polunovsky, V. A.; Houghton, Peter J. Series: Cancer Drug Discovery and Development. Num Pages: 304 pages, 3 colour tables, biography. BIC Classification: MJCL. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 23. Weight in Grams: 695.
The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment – targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even ... Read more
The main objective of this book is to provide an up-to-date survey of the rapidly advancing eld of cancer therapy. Moreover, since our knowledge in this area rapidly evolves, some data have got obsolete during the process of book editing. Our understanding of the mechanisms involved in cancer genesis and progression underwent unprecedented expansion during the last decade, opening a new era of cancer treatment – targeted therapy. The surge in this area results in no small part from studies conducted jointly by basic health scientists and clinical investigators. It is our hope that this book will help foster even ... Read more
Product Details
Format
Hardback
Publication date
2010
Publisher
Humana Press Inc. United States
Number of pages
304
Condition
New
Series
Cancer Drug Discovery and Development
Number of Pages
304
Place of Publication
Totowa, NJ, United States
ISBN
9781603272704
SKU
V9781603272704
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for MTOR Pathway and MTOR Inhibitors in Cancer Therapy